24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publication dates

Stem Cell Industry, November 2014 Market Reports from Top Publishers

You might be interested in: Medical Equipment, Therapeutics, Cancer, more »


 
1-10 of about 200 reports for Stem Cell

Mesoblast Limited (MSB) - Financial and Strategic SWOT Analysis Review

Mesoblast Limited (MSB) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... cells (dpscs) and hematopoietic stem cells (hscs). Mesoblast serves various therapeutic areas such as immunologic/ inflammatory, cardiac vascular, spine disease, ophthalmolog, neurologic and oncology ...

BIONET Corp. (Symbol:1784) SWOT Analysis, Strategy, Revenues and Profits

BIONET Corp. (Symbol:1784) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Diagnosis, genesis-24 pre-implantation genetic screening services, down syndrome screening methods, spinal muscular atrophy genetic testing, dental pulp stem cell storage service, and preventive genetic ...

MediPost Co., Ltd. (Symbol:078160) SWOT Analysis, Strategy, Revenues and Profits

MediPost Co., Ltd. (Symbol:078160) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Cord blood derived mesenchymal stem cells (hucb-mscs). The company markets products through brands such as cartistem, neurostem, pneumostem and promostem. It collaborates with sungkyunkwan university ...

StemCells, Inc. (STEM) - Financial and Strategic SWOT Analysis Review

StemCells, Inc. (STEM) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Note*: some sections may be missing if data is unavailable for the company list of tables stemcells, inc., Key information stemcells, inc., Key ratios ...

TiGenix NV (Symbol:TIG) SWOT Analysis, Strategy, Revenues and Profits

TiGenix NV (Symbol:TIG) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Tigenix nv (tig) - financial and strategic swot analysis review summarytigenix nv (tigenix) is a cell therapy company. The company provides clinical stage pipeline of adult stem cell ...

Forticell Bioscience, Inc. - Strategic SWOT Analysis Review

Forticell Bioscience, Inc. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Ulcers, and also used in cosmetic surgery, and other chronic and acute wounds applications. It conducts research on regenerative medicine and stem cell therapy. The company markets its products through its ...

VITA 34 International AG (V3V) - Financial and Strategic SWOT Analysis Review

VITA 34 International AG (V3V) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Processes, and stores stem cells from umbilical cord blood. Its products include vitaplus, vitaplus25, vitaplus50, vitapluscordtissue, vitapluscordtissue25, and vitapluscordtissue50. Vita 34 research ...

Medistem, Inc. (MEDS) - Strategic SWOT Analysis Review

Medistem, Inc. (MEDS) - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... And commercialization of biological technologies. Its technologies are related to adult stem cell extraction and manipulation for use in the treatment of inflammatory and degenerative diseases. The company offers ...

Biolife Solutions, Inc. (Symbol:BLFS) SWOT Analysis, Strategy, Revenues and Profits

Biolife Solutions, Inc. (Symbol:BLFS) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Cord tissue stem cells, and bloodstor. The company caters to regenerative medicine, biobanking, and drug discovery markets. Biolife solutions is headquartered in bothell, washington, the us ...

GENova Biotherapeutics, Inc. (Symbol:GVBP) SWOT Analysis, Strategy, Revenues and Profits

GENova Biotherapeutics, Inc. (Symbol:GVBP) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... The company's stem cell technology is a two-way approach including a method to identify specific biomarkers for breast cancer cells and various methods to destroy these malignancies. Genova is headquartered ...

About 1 300 reports for Stem Cell

Download Unlimited Documents from Trusted Public Sources

Stem Cell Industry in Russia

  • The Social Legitimation of Biomedical Technologies in Russia Co
  • January 2013
    21 pages
  • Stem Cell  

  • Russian Federat  

View report >

Annual Report 2014

January 2014

3 Companies for Stem Cell

Read our Company Profiles

Athersys Inc.

United States

Bioheart Inc.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.